Treasury has released its terms of reference for the ASIC Industry Funding Model which industry associations hope will address the burden placed on financial advice. With fewer advisers left in the industry it’s imperative the review find a balance that doesn’t leave advisers carrying more than their fair share.
being discovered and saying that it works to it being widely available? the big issue a we challenge have at the moment is payment for this. at the moment is payment for this. at the moment, treatment for people with severe haemophilia costs about 150- £200,000 a with severe haemophilia costs about 150 £200,000 a year. gene therapy could cost anywhere between £1 million at two and a half million pounds. we need to work on the reimbursement funding model, that is something we are working on with other people. it may be that it ends up other people. it may be that it ends up being a mortgage payment, the government or nhs would pay that money up front and would pay it over a few years depending on the results. we hope within the next 7-12 results. we hope within the next 7 12 months we can get that funding model in place and that we can work out how this will be reimbursed so it comes to market and people do have the opportunity of this as a treatment option. treatment option. that1
it could be available within the next three years, why that time lag from it being discovered and saying that it works to it being widely available? the big issue and we challenge have at the moment is payment for this. at the moment, treatment for people with severe haemophilia costs about £150,000-£200,000 a year. gene therapy could cost anywhere between £1 million and two and a half million pounds. we need to work on the reimbursement funding model, that is something we are working on with a number of other people. it may be that it ends up being a mortgage payment, so the government or nhs wouldn t pay that money up front and would pay it over a few years depending on the results. we hope within the next 7 12 months we can get that funding model in place and that we can work out how this will be reimbursed so it comes to market and people do have the opportunity of this as a treatment option.
The Financial Ombudsman Service (FOS) has published a discussion paper on possible changes to its future funding model, seeking feedback from financial services organisations, trade bodies, consumer groups and other stakeholders.
World Health Organization members formally agreed on Tuesday to a plan to overhaul its funding model which has been described as "fundamentally rotten" due to its over-reliance on the whims of donors.